UNSPSC 51271634: Pyrrocaine hydrochloride

This classification denotes an anesthetic agent with the molecular formula C14H20N2O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9CST8J378F, chemically known as 1-pyrrolidineaceto-2,6-xylidide but more generally known as pyrrocaine hydrochloride, which bears US NIH Compound Identifier 24361. European Medicines Agency schedules Pyrrocaine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15068MIG.

Most nations, for tariff and trade purposes, schedule pyrrocaine hydrochloride under HS 29339990 and SITC 51577. As of Q4 2014, PYRROCAINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Pyrrocaine hydrochloride bears US NLM identifiers UMLS ID C2825619 and NCI Concept Code C81405. SMILES: CC1CCCC(C1NC(=O)CN2CCCC2)C.CL.

UNSPSC 51271634 Pyrrocaine hydrochloride, a Commodity code, encompasses local anesthetic pharmaceutical products that state and local health systems procure through cooperative purchasing agreements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) is actively soliciting manufacturers and authorized distributors of generic multi-source pharmaceuticals and over-the-counter products under this code, including pyrrocaine hydrochloride and similar local anesthetics. The scope of work involves supplying finished pharmaceutical products with precise National Drug Codes (NDC), SKUs, and UPCs through designated wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) to state and local government health facilities. Vendors must certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), maintain contractual relationships with at least two of the three authorized wholesalers with chargeback systems in place, and support electronic data interchange (EDI) capability. Participating jurisdictions include Minnesota and Oregon; the solicitation does not identify specific set-aside designations.

The primary recent opportunity is MMCAP's RFP S1070000015802, posted January 20, 2026, with proposals due March 26, 2026. MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement, is establishing multiple contracts with a two-year term for new vendors and optional extensions at MMCAP's discretion; incumbent vendors' amendments align with existing agreements through June 30, 2028. Evaluation is weighted heavily on price competitiveness (75 percent), with remaining points distributed across fixed pricing (10 percent), compliance with administrative data formatting (5 percent), EDI capability (5 percent), and agreement to a 3 percent administrative fee (5 percent). Awarded vendors must comply with performance penalties ranging from $200 to $1,500 per violation and maintain comprehensive insurance coverage including commercial general liability of $5,000,000 per occurrence. Products must be available in the marketplace by May 15, 2026, with contract effectiveness set for July 1, 2026.